We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · November 23, 2021

High Incidence of Thromboembolism in Patients With mRCC Treated With Immunotherapy

Targeted oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Targeted oncology
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy
Target Oncol 2021 Nov 06;[EPub Ahead of Print], IY Sheng, S Gupta, CA Reddy, D Angelini, P Funchain, TA Sussman, J Sleiman, MC Ornstein, K McCrae, AA Khorana

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading